The site uses anonymous third party analytic cookies: in accessing any element/area of the site outside of this banner, you consent to receiving cookies.

Knowledge Hub

Soundbites from the ԰AV: Access to cancer therapies – Understanding the challenges of pharmacy aseptic manufacturing units

In this new series in our ‘Soundbites from the ԰AV’, we speak to Rob Duncombe, Chief Pharmacist for The Royal Marsden ԰AV Foundation Trust for a conversation dedicated to understanding the challenges of pharmacy aseptic manufacturing units.

Watch each episode in the series chronologically by clicking the videos below:

Episode 1: The challenges of the aseptic manufacturing units


Episode 2: Overcoming the challenges


Episode 3: Capacity issues influencing treatment choices (For HCPs only)


Episode 4: Are treatment change decisions being made locally or by the cancer alliances?


Episode 5: Demonstrating the value of switching treatments


Episode 6: Challenges for the ԰AV & aseptic manufacturing units forward


Episode 7: Implications of the closures of aseptic manufacturing units


Episode 8: What can industry do to support manufacturing of cancer treatments?

You may also be interested in